Semaglutide 10mg per vial

Semaglutide falls into the category of compounds known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Its mechanism of action involves mimicking the GLP-1 hormone, a natural hormone released in the gastrointestinal tract after meals.

GLP-1 plays a pivotal role in stimulating insulin production by the body, thereby lowering blood sugar levels. Consequently, healthcare professionals have been employing Semaglutide for over 15 years to manage Type 2 diabetes.

However, GLP-1, when present in elevated levels, also influences the brain regions responsible for suppressing appetite and triggering feelings of fullness. When combined with a healthy diet and exercise habits, Semaglutide may lead to substantial weight loss. Additionally, it may reduce the risk of conditions such as cancer, diabetes, and heart disease in participants who are overweight or obese.